Volume 68, Issue 6, Pages (December 2005)

Slides:



Advertisements
Similar presentations
Volume 65, Issue 1, Pages (January 2004)
Advertisements

Canonical Wnt/β-catenin signaling mediates transforming growth factor-β1-driven podocyte injury and proteinuria  Dan Wang, Chunsun Dai, Yingjian Li, Youhua.
Plasmin is not protective in experimental renal interstitial fibrosis1
Volume 131, Issue 3, Pages (September 2006)
Tranilast attenuates connective tissue growth factor-induced extracellular matrix accumulation in renal cells  W. Qi, X. Chen, S. Twigg, T.S. Polhill,
Volume 76, Issue 1, Pages (July 2009)
The aging kidney Kidney International
Volume 56, Issue 4, Pages (October 1999)
Anders A. Tveita, Ole P. Rekvig, Svetlana N. Zykova 
Volume 55, Issue 2, Pages (February 1999)
Volume 58, Issue 5, Pages (November 2000)
Smad7 gene transfer inhibits peritoneal fibrosis
Noninhibitory PAI-1 enhances plasmin-mediated matrix degradation both in vitro and in experimental nephritis  Y. Huang, W.A. Border, D.A. Lawrence, N.A.
Volume 61, Issue 5, Pages (May 2002)
Volume 58, Issue 6, Pages (December 2000)
Volume 75, Issue 2, Pages (January 2009)
M.H.A. Baccora, P. Cortes, C. Hassett, D.W. Taube, J. Yee 
Volume 67, Issue 3, Pages (March 2005)
TGF-β isoforms in renal fibrogenesis
Volume 67, Issue 4, Pages (April 2005)
Volume 66, Issue 5, Pages (November 2004)
Volume 56, Issue 5, Pages (November 1999)
Volume 64, Issue 5, Pages (November 2003)
Volume 77, Issue 11, Pages (June 2010)
Volume 62, Issue 3, Pages (September 2002)
Heterozygous disruption of activin receptor–like kinase 1 is associated with increased renal fibrosis in a mouse model of obstructive nephropathy  José.
Volume 56, Issue 3, Pages (September 1999)
Volume 65, Issue 6, Pages (June 2004)
Hiroyuki Yanagisawa, Nobuyuki Yamazaki, Gen Sato, Osamu Wada 
Volume 73, Issue 4, Pages (February 2008)
Volume 60, Issue 2, Pages (August 2001)
PPARα agonist fenofibrate improves diabetic nephropathy in db/db mice
Oliver Vonend, Clare M. Turner  Kidney International 
Gene transfer of truncated IκBα prevents tubulointerstitial injury
Volume 67, Issue 2, Pages (February 2005)
Renoprotective role of the vitamin D receptor in diabetic nephropathy
Volume 55, Issue 2, Pages (February 1999)
Volume 56, Issue 4, Pages (October 1999)
Volume 70, Issue 10, Pages (November 2006)
Abnormal development of glomerular endothelial and mesangial cells in mice with targeted disruption of the lama3 gene  C.K. Abrass, A.K. Berfield, M.C.
Volume 66, Issue 5, Pages (November 2004)
Volume 63, Issue 6, Pages (June 2003)
Volume 68, Issue 2, Pages (August 2005)
Volume 85, Issue 2, Pages (January 2014)
Volume 62, Pages S12-S22 (December 2002)
Volume 73, Issue 6, Pages (March 2008)
Volume 54, Issue 4, Pages (October 1998)
Volume 68, Issue 2, Pages (August 2005)
Volume 66, Issue 5, Pages (November 2004)
Volume 82, Issue 3, Pages (August 2012)
Volume 67, Issue 6, Pages (June 2005)
Knockdown of Stat3 activity in vivo prevents diabetic glomerulopathy
Chien-Te Lee, Viet M. Huynh, Li-Wen Lai, Yeong-Hau H. Lien 
Volume 60, Issue 5, Pages (November 2001)
Volume 65, Issue 6, Pages (June 2004)
Volume 67, Issue 6, Pages (June 2005)
Laminin-8/9 is synthesized by rat glomerular mesangial cells and is required for PDGF- induced mesangial cell migration  Kim Hansen, Christine K. Abrass 
Volume 56, Issue 6, Pages (December 1999)
Volume 63, Issue 1, Pages (January 2003)
Production of hemopexin by TNF-α stimulated human mesangial cells
Jens Gaedeke, Nancy A. Noble, Wayne A. Border  Kidney International 
Volume 58, Issue 6, Pages (December 2000)
T-PA promotes glomerular plasmin generation and matrix degradation in experimental glomerulonephritis  Masashi Haraguchi, Wayne A. Border, Yufeng Huang,
Volume 21, Issue 2, Pages (February 2013)
Volume 59, Issue 2, Pages (February 2001)
Plasmin is not protective in experimental renal interstitial fibrosis1
Volume 65, Issue 6, Pages (June 2004)
Volume 65, Issue 1, Pages (January 2004)
Volume 62, Issue 5, Pages (November 2002)
Volume 70, Issue 1, Pages (July 2006)
Presentation transcript:

Volume 68, Issue 6, Pages 2651-2666 (December 2005) Plasminogen activator inhibitor-1 gene deficiency attenuates TGF-β1-induced kidney disease  Suren Krag, Carl Christian Danielsen, Peter Carmeliet, Jens Nyengaard, Lise Wogensen  Kidney International  Volume 68, Issue 6, Pages 2651-2666 (December 2005) DOI: 10.1111/j.1523-1755.2005.00737.x Copyright © 2005 International Society of Nephrology Terms and Conditions

Figure 1 (A) Real-time RT-PCR analysis of PAI-1 mRNA in 10-week-old TGF-β1+ (▴, •) and TGF-β1- (▵, ○), PAI-1 WT (▵, ▴), or PAI-1 KO (○, •) mice, (-) mean. Results are expressed as the ratio between PAI-1 and GAPDH mRNA expression. (B) Representative PAI-1 stained glomeruli from 34-week-old PAI-1 WT TGF-β1-, PAI-1 WT TGF-β1+, and PAI-1 KO TGF-β1+ mice (original magnification ×250). Arrows mark PAI-1 positive reaction in the glomeruli. Kidney International 2005 68, 2651-2666DOI: (10.1111/j.1523-1755.2005.00737.x) Copyright © 2005 International Society of Nephrology Terms and Conditions

Figure 2 Real-time RT-PCR analysis of (A) murine TGF-β1 mRNA and (B) murine βig-h3 mRNA in 10- and 34-week-old TGF-β1+ (▴, •) and TGF-β1- (▵, ○), PAI-1 WT (▵, ▴) or PAI-1 KO (○, •) mice. Results are expressed as the ratio between TGF-β1 and GAPDH mRNA expression. (C) Ratio between βig-h3:TGF-β1 in 10- and 34-week-old TGF-β1+ (▴, •) and TGF-β1- (▵, ○), PAI-1 WT (▵, ▴) or PAI-1 KO (○, •) mice, (-) mean. #P < 0.05 vs. TGF-β1- of same PAI genotype. Kidney International 2005 68, 2651-2666DOI: (10.1111/j.1523-1755.2005.00737.x) Copyright © 2005 International Society of Nephrology Terms and Conditions

Figure 3 (A) Representative PAS stained glomeruli from 34-week-old PAI-1 WT TGF-β1- (A), PAI-1 WT TGF-β1+ (B), and PAI-1 KO TGF-β1+ mice (C). (B) (a-d) EM photographs of glomeruli from 16-week-old mice (original magnification ×1400). (e-h) EM photographs of the basal membrane (original magnification ×7900). PAI-1 WT TGF-β1- (a, e), PAI-1 WT TGF-β1+ (b, f), PAI-1 KO TGF-β1- (c, g), and PAI-1 KO TGF-β1+ (d, h). (C) (a-h) Anti-collagen IV α1-2 (a-d) and anti-laminin β2 (e-h) immunostaining from 16-week-old mice (original magnification ×400). PAI-1 WT TGF-β1- (a, e), PAI-1 WT TGF-β1+ (b, f), PAI-1 KO TGF-β1- (c, g), and PAI-1 KO TGF-β1+ (d, h). Kidney International 2005 68, 2651-2666DOI: (10.1111/j.1523-1755.2005.00737.x) Copyright © 2005 International Society of Nephrology Terms and Conditions

Figure 4 Real-time RT-PCR analysis of collagen type I and III and fibronectin mRNA in 10- (A) and 34-week-old (B) TGF-β1+ (▴, •) and TGF-β1- (▵, ○), PAI-1 WT (▵, ▴), or PAI-1 KO (○, •) mice, (-) mean. Results are expressed as the ratio between ECM molecules and GAPDH mRNA expression. *P < 0.05 vs. PAI-1 KO TGF-β1+. #P < 0.05 vs. TGF-β1- of same PAI genotype. Kidney International 2005 68, 2651-2666DOI: (10.1111/j.1523-1755.2005.00737.x) Copyright © 2005 International Society of Nephrology Terms and Conditions

Figure 5 Total collagen content in 16- and 34-week-old TGF-β1+ (▴, •) and TGF-β1- (▵, ○), PAI-1 WT (▵, ▴), or PAI-1 KO (○, •) mice. Data are expressed as μg collagen/mg dried tissue, (-) mean. *P < 0.05 vs. PAI-1 KO TGF-β1+. #P < 0.05 vs. TGF-β1- of same PAI genotype. Kidney International 2005 68, 2651-2666DOI: (10.1111/j.1523-1755.2005.00737.x) Copyright © 2005 International Society of Nephrology Terms and Conditions

Figure 6 (A) Western blot determination of fibronectin content of whole kidney extracts in 34-week-old mice: TGF-β1+ (▴, •) and TGF-β1- (▵, ○), PAI-1 WT (▵, ▴), or PAI-1 KO (○, •) mice, (-) mean.*P < 0.05 vs. PAI-1 KO TGF-β1+. #P < 0.05 vs. TGF-β1- of same PAI genotype. (B) Representative Western blot for fibronectin, lane 1: Mouse fibronectin standard. Lanes 2-5: Samples from 34-week-old mice. Kidney International 2005 68, 2651-2666DOI: (10.1111/j.1523-1755.2005.00737.x) Copyright © 2005 International Society of Nephrology Terms and Conditions

Figure 7 Kidneys from 34-week-old mice immunostained with antibodies against collagen I (A-C) and III (D-F). PAI-1 WT TGF-β1- (A, D), PAI-1 WT TGF-β1+ (B, E), and PAI-1 KO TGF-β1+ (C, F) (original magnification ×40). Kidney International 2005 68, 2651-2666DOI: (10.1111/j.1523-1755.2005.00737.x) Copyright © 2005 International Society of Nephrology Terms and Conditions

Figure 8 Plasmin activity in kidney extracts without (A) or with (B) addition of plasminogen to evaluate the combined biological effect of t-PA and u-PA. PAI-1 WT TGF-β1- PAI-1 WT TGF-β1+ PAI-1 KO TGF-β1- and PAI-1 KO TGF-β1+. Data are given as mean ± SD. Kidney International 2005 68, 2651-2666DOI: (10.1111/j.1523-1755.2005.00737.x) Copyright © 2005 International Society of Nephrology Terms and Conditions

Figure 9 Gel zymography of MMP-2 (A) and MMP-9 (B) in 10-week-old TGF-β1+ and TGF-β1-, PAI-1 WT, or PAI-1 KO mice. Results are expressed as mean ± SD. (C) A representative example of a zymography gel with samples from PAI-1 WT TGF-β1+ (lanes 2, 6), PAI-1 WT TGF-β1- (lanes 3, 7), PAI-1 KO TGF-β1+ (lanes 4, 8), and PAI-1 KO TGF-β1- (lanes 5, 9) mice. Lane 1 and 10 are MMP-2 and -9 standards, respectively. Kidney International 2005 68, 2651-2666DOI: (10.1111/j.1523-1755.2005.00737.x) Copyright © 2005 International Society of Nephrology Terms and Conditions

Figure 10 In situ zymography. Representative micrographs of glomeruli at high magnification (×400 original) (A-C) and cortex at a lower magnification (×40 original magnification) (D-G). PAI-1 WT TGF-β1- (A, D), PAI-1 WT TGF-β1+ (B, E), and PAI-1 KO TGF-β1+ (C, F) mice. Negative control (G). (A-C) Arrows mark the glomeruli, and arrowheads mark the mesangial region. (D-F) Arrowheads mark the interstitium/tubular basement membranes. Kidney International 2005 68, 2651-2666DOI: (10.1111/j.1523-1755.2005.00737.x) Copyright © 2005 International Society of Nephrology Terms and Conditions